• LAST PRICE
    3.8800
  • TODAY'S CHANGE (%)
    Trending Down-0.1000 (-2.5126%)
  • Bid / Lots
    3.7500/ 15
  • Ask / Lots
    3.9800/ 13
  • Open / Previous Close
    3.9400 / 3.9800
  • Day Range
    Low 3.7300
    High 3.9600
  • 52 Week Range
    Low 2.9800
    High 13.8500
  • Volume
    154,946
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 3.98
TimeVolumeRPTX
09:32 ET70013.84
09:36 ET5003.86
09:38 ET1003.885
09:39 ET5583.9199
09:41 ET48943.94
09:45 ET1173.9299
09:52 ET3003.885
09:56 ET19493.8614
09:57 ET3803.9
10:06 ET2003.885
10:10 ET2703.8614
10:12 ET67263.88
10:14 ET1003.89
10:15 ET6003.89
10:17 ET18993.9
10:19 ET1003.9
10:24 ET8583.9
10:26 ET1253.9001
10:28 ET29303.925
10:32 ET1003.9
10:33 ET1003.91
10:35 ET3003.915
10:42 ET1003.91
10:46 ET2003.9
10:50 ET45893.905
10:53 ET9203.91
10:55 ET3903.91
11:00 ET6003.92
11:02 ET1003.91
11:04 ET3003.92
11:06 ET1003.91
11:08 ET7003.91
11:09 ET16803.9
11:13 ET2003.895
11:20 ET1003.895
11:24 ET2963.9086
11:26 ET1003.895
11:36 ET13833.895
11:42 ET8433.8914
11:44 ET2003.9
11:45 ET1003.89
11:51 ET50003.9
11:54 ET3003.9
11:56 ET1003.9
11:58 ET1003.9
12:12 ET22003.9
12:14 ET5203.9
12:16 ET1003.9
12:21 ET1003.89
12:30 ET2163.9
12:32 ET6003.89
12:34 ET1003.89
12:36 ET1003.89
12:38 ET1003.89
12:39 ET17003.87
12:41 ET7003.89
12:43 ET5003.86
12:50 ET28153.8104
12:52 ET2003.81
12:54 ET8003.82
12:57 ET1003.82
01:03 ET1003.82
01:08 ET1003.82
01:12 ET17003.82
01:14 ET1003.83
01:15 ET17003.82
01:17 ET2003.82
01:19 ET1003.82
01:21 ET4263.82
01:24 ET1003.835
01:26 ET84693.9
01:28 ET1003.885
01:30 ET6003.9
01:33 ET1003.895
01:37 ET9003.9
01:39 ET1003.89
01:44 ET5003.88
01:48 ET1003.89
01:50 ET1003.89
01:53 ET4003.87
01:55 ET1003.885
01:57 ET6643.885
02:00 ET3403.8976
02:06 ET13083.875
02:27 ET2163.8809
02:40 ET3003.86
02:45 ET1003.83
02:47 ET1003.831
02:49 ET2003.85
02:54 ET3003.86
03:00 ET8523.81
03:05 ET6183.82
03:07 ET18003.815
03:09 ET7003.79
03:12 ET18983.76
03:14 ET3003.75
03:16 ET2003.73
03:18 ET4273.765
03:20 ET8503.77
03:21 ET19353.77
03:30 ET1003.78
03:41 ET1003.775
03:48 ET58623.835
03:50 ET21163.86
03:52 ET1003.8401
03:54 ET4603.84
03:56 ET4003.845
03:57 ET149023.89
03:59 ET100443.88
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesRPTX
Repare Therapeutics Inc
170.6M
-3.5x
---
United StatesRCEL
AVITA Medical Inc
245.4M
-5.2x
---
United StatesDTIL
Precision BioSciences Inc
90.1M
-2.2x
---
United StatesMGX
Metagenomi Inc
245.4M
-3.3x
---
United StatesCSBR
Champions Oncology Inc
62.7M
-6.4x
---
United StatesCRBU
Caribou Biosciences Inc
191.5M
-1.3x
---
As of 2024-06-09

Company Information

Repare Therapeutics Inc. is a clinical-stage precision oncology company focused on the development of synthetic lethality (SL)-based therapies for patients with cancer. The Company is engaged in the proprietary SL approach to the discovery and development of novel therapeutics. It uses its genome-wide, CRISPR-enabled SNIPRx platform to systematically discover and develop cancer therapies focused on genomic instability, including deoxyribonucleic acid (DNA) damage repair. The Company’s initial product candidate, camonsertib (RP-3500 or RG6526), a potent and selective oral small molecule inhibitor of Ataxia-Telangiectasia and Rad3-related protein kinase (ATR) for the treatment of solid tumors with specific DNA damage repair-related genomic alterations, including those in the ataxia telangiectasia mutated kinase (ATM) gene as part of a network of 16 STEP2-identified genomic alterations. Its other pipeline includes Lunresertib PKMYT1 Inhibitor and RP-3467 polymerase theta (Pol0) Inhibitor.

Contact Information

Headquarters
7210 Frederick-Banting, Suite 100ST-LAURENT, QC, Canada H4S 2A1
Phone
---
Fax
---

Executives

Independent Chairman of the Board
Thomas Civik
President, Chief Executive Officer, Director
Lloyd Segal
Chief Financial Officer, Executive Vice President
Steve Forte
Executive Vice President, Chief Scientific Officer
Michael Zinda
Executive Vice President, Chief Medical Officer
Maria Koehler

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$170.6M
Revenue (TTM)
$97.9M
Shares Outstanding
42.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.74
EPS
$-1.10
Book Value
$5.03
P/E Ratio
-3.5x
Price/Sales (TTM)
1.7
Price/Cash Flow (TTM)
---
Operating Margin
-72.27%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.